(Q36995218)

17 August 2017

1 reference

title

Tuberculosis: drug resistance, fitness, and strategies for global control (English)

1 reference

17 August 2017

0 references

1

Erik C Böttger

1 reference

17 August 2017

Burkhard Springer

2

1 reference

17 August 2017

publication date

7 November 2007

1 reference

European Journal of Pediatrics

17 August 2017

published in

1 reference

17 August 2017

volume

167

1 reference

17 August 2017

issue

2

1 reference

17 August 2017

page(s)

141-148

1 reference

https://scigraph.springernature.com/pub.10.1007/s00431-007-0606-9

17 August 2017

exact match

0 references

cites work

A threshold value for the time delay to TB diagnosis

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00431-007-0606-9

Worldwide Incidence of Multidrug‐Resistant Tuberculosis

21 January 2018

1 reference

12 December 2020

Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment.

1 reference

12 December 2020

The competitive cost of antibiotic resistance in Mycobacterium tuberculosis

1 reference

12 December 2020

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

1 reference

12 December 2020

Does DOTS work in populations with drug-resistant tuberculosis?

1 reference

12 December 2020

Fitness of antibiotic-resistant microorganisms and compensatory mutations.

1 reference

12 December 2020

Fitness cost of chromosomal drug resistance-conferring mutations

1 reference

12 December 2020

Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands

1 reference

12 December 2020

The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol.

1 reference

12 December 2020

Effects of environment on compensatory mutations to ameliorate costs of antibiotic resistance

1 reference

12 December 2020

Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update

1 reference

12 December 2020

Crystal structure of Mycobacterium tuberculosis catalase-peroxidase

1 reference

12 December 2020

Mechanism of thioamide drug action against tuberculosis and leprosy

1 reference

12 December 2020

Role of embB codon 306 mutations in Mycobacterium tuberculosis revisited: a novel association with broad drug resistance and IS6110 clustering rather than ethambutol resistance

1 reference

12 December 2020

Impact of HIV infection on the epidemiology of tuberculosis in a peri-urban community in South Africa: the need for age-specific interventions

1 reference

12 December 2020

Mycobacterium tuberculosis KatG(S315T) catalase-peroxidase retains all active site properties for proper catalytic function

1 reference

12 December 2020

MYCOBACTERIA: LABORATORY METHODS FOR TESTING DRUG SENSITIVITY AND RESISTANCE

1 reference

12 December 2020

Effect of rpoB mutations conferring rifampin resistance on fitness of Mycobacterium tuberculosis

1 reference

12 December 2020

The biological cost of antibiotic resistance

1 reference

12 December 2020

Use of smear-positive samples to assess the PCR-based genotype MTBDR assay for rapid, direct detection of the Mycobacterium tuberculosis complex as well as its resistance to isoniazid and rifampin

1 reference

12 December 2020

Mycobacteria: genetics of resistance and implications for treatment

1 reference

12 December 2020

Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis.

1 reference

12 December 2020

Recent advances in epidemiological research in tuberculosis

1 reference

12 December 2020

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic

1 reference

12 December 2020

Molecular epidemiology of tuberculosis in the Netherlands: a nationwide study from 1993 through 1997.

1 reference

12 December 2020

Standard short-course chemotherapy for drug-resistant tuberculosis: treatment outcomes in 6 countries

1 reference

12 December 2020

Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes

1 reference

12 December 2020

[Mechanisms of the action of drugs in the short-course chemotherapy]

1 reference

12 December 2020

Correlation of molecular resistance mechanisms and phenotypic resistance levels in streptomycin-resistant Mycobacterium tuberculosis

1 reference

12 December 2020

TREATMENT of pulmonary tuberculosis with streptomycin and para-aminosalicylic acid; a Medical Research Council investigation

1 reference

12 December 2020

Ethambutol resistance testing by mutation detection.

1 reference

12 December 2020

Detection of embB306 mutations in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis from Northwestern Russia: implications for genotypic resistance testing

1 reference

12 December 2020

Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants

1 reference

12 December 2020

Antimicrobial resistance in tuberculosis: an international perspective.

1 reference

12 December 2020

Drug-resistant tuberculosis

1 reference

12 December 2020

Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis

1 reference

12 December 2020

Failure of directly observed treatment for tuberculosis in Africa: a call for new approaches

1 reference

12 December 2020

Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods

1 reference

12 December 2020

Classification of drug-resistant tuberculosis in an epidemic area

1 reference

12 December 2020

Present aspects of bacterial resistance in tuberculosis

1 reference

12 December 2020

Studies on isoniazid and tubercle bacilli. II. The growth requirements, catalase activities, and pathogenic properties of isoniazid-resistant mutants.

1 reference

12 December 2020

Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis.

1 reference

12 December 2020

Functional insights from the structure of the 30S ribosomal subunit and its interactions with antibiotics

1 reference

12 December 2020

A controlled trial of six months chemotherapy in pulmonary tuberculosis. Second report: results during the 24 months after the end of chemotherapy. British Thoracic Association

1 reference

12 December 2020

Genome and MIC stability in Mycobacterium tuberculosis and indications for continuation of use of isoniazid in multidrug-resistant tuberculosis.

1 reference

12 December 2020

Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans.

1 reference

12 December 2020

Drug Resistance and Fitness inMycobacterium tuberculosisInfection

1 reference

12 December 2020

The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol

1 reference

12 December 2020

High-dose isoniazid therapy for isoniazid-resistant murine Mycobacterium tuberculosis infection

1 reference

12 December 2020

10.1007/S00431-007-0606-9

Identifiers

DOI

1 reference

17 August 2017

1 reference